Key result
Administration of magnesium aspartate immediately stopped recurrent Torsades de Pointes tachycardia in a 15-month-old girl treated with sotalol for Wolff-Parkinson-White syndrome.
Why the study?
Does magnesium aspartate stop sotalol-induced Torsades de Pointes in a pediatric patient?
Case Report (n=1)
No
Does magnesium aspartate stop sotalol-induced Torsades de Pointes in a pediatric patient?
Magnesium aspartate successfully terminated sotalol-induced Torsades de Pointes in a 15-month-old child.
Answers are grounded in this paper and cite their sources.
May support magnesium aspartate for sotalol-induced TdP in infants; leaves open need for prospective pediatric data.
Torsades de points (Tdp) is a form of ventricular tachycardia, and its occurrence in childhood is very rare. In adult patients treated with sotalol, Tdp has been reported to the occur with an incidence of 2%-4%. In children who are treated with sotalol, occurrence of Tdp has been reported in only a single case. A 15-month-old girl with Wolff-Parkinson-White syndrome developed recurrent syncopal attacks. She had been treated with sotalol 1.5 mg/kg daily since shortly after birth because of recurrent episodes of paroxysmal supraventricular tachycardia. ECG monitoring exhibited frequent Tdp tachycardia. Serum electrolyte levels were normal. Echocardiographic analysis excluded a structural heart defect and did not show any signs of myocardial infection. Sotalol treatment was stopped and an infusion with lidocaine was started. Despite this therapy the Tdp continued. Magnesium aspartate was then administered, which immediately stopped the Tdp. As no other reason was evident, Tdp in this child has to be judged as a proarrhythmia related to sotalol therapy.
No takes yet. Share an insight, caveat, or question.
Sasse et al. (1998) conducted a case report in Torsades de Pointes tachycardia associated with sotalol (n=1). Magnesium aspartate was evaluated on Resolution of Torsades de Pointes tachycardia. Administration of magnesium aspartate immediately stopped recurrent Torsades de Pointes tachycardia in a 15-month-old girl treated with sotalol for Wolff-Parkinson-White syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: